Ergotamine/cobicistat/darunavir interaction | springermedizin.de

Springer Medizin

nach oben

Reactions Weekly

Erschienen in:

01.07.2022 | Case report

Ergotamine/cobicistat/darunavir interaction

Coronary artery vasospasm secondary to ergotism: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event
* Drug interaction

…

Anzeige

Wu C-E, et al. A rare complication of coronary vasospasm associated with concomitant use of ergotamine, cobicistat, and darunavir. Antiviral Therapy 27: No. 2, 23 Apr 2022. Available from: URL: http://doi.org/10.1177/13596535211068957

Titel: Ergotamine/cobicistat/darunavir interaction
Coronary artery vasospasm secondary to ergotism: case report
Publikationsdatum: 01.07.2022
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-19230-5